This study identified HER2 and Bcl-2 as independent predictors of a pCR through a logistic regression analysis, and significant reductions in tumor size were noted in HER2-positive/Tau-negative/Bcl-2-negative tumors with a high Ki67 index. This evidence concerns the gene MAPT and neoplasm.